Changqing Hao

816 total citations
27 papers, 400 citations indexed

About

Changqing Hao is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Changqing Hao has authored 27 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 16 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Changqing Hao's work include Esophageal Cancer Research and Treatment (21 papers), Esophageal and GI Pathology (9 papers) and Gastric Cancer Management and Outcomes (8 papers). Changqing Hao is often cited by papers focused on Esophageal Cancer Research and Treatment (21 papers), Esophageal and GI Pathology (9 papers) and Gastric Cancer Management and Outcomes (8 papers). Changqing Hao collaborates with scholars based in China, United States and France. Changqing Hao's co-authors include Wenqiang Wei, Jinwu Wang, Guoqing Wang, Guohui Song, Bianyun Li, Deli Zhao, Liyan Xue, Christian C. Abnet, Ning Lü and You‐Lin Qiao and has published in prestigious journals such as Scientific Reports, Journal of Membrane Science and International Journal of Cancer.

In The Last Decade

Changqing Hao

27 papers receiving 392 citations

Peers

Changqing Hao
Seoung Ho Choi South Korea
Tao Deng China
Jae Yeon Jung United States
Jae Seon Kim South Korea
Seoung Ho Choi South Korea
Changqing Hao
Citations per year, relative to Changqing Hao Changqing Hao (= 1×) peers Seoung Ho Choi

Countries citing papers authored by Changqing Hao

Since Specialization
Citations

This map shows the geographic impact of Changqing Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changqing Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changqing Hao more than expected).

Fields of papers citing papers by Changqing Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changqing Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changqing Hao. The network helps show where Changqing Hao may publish in the future.

Co-authorship network of co-authors of Changqing Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Changqing Hao. A scholar is included among the top collaborators of Changqing Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changqing Hao. Changqing Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Xiaogang, et al.. (2025). A novel loose nanofiltration membrane with high permeance based on aqueous monomer 2,4,6-Trimethyl-m-phenylenediamine for efficient dye/salt separation. Separation and Purification Technology. 363. 132292–132292. 6 indexed citations
2.
Lin, Yu, Zhen‐Liang Xu, Li Li, et al.. (2024). Catalyst pre-diffusion: An efficient strategy for the construction of COF nanofiltration membranes. Desalination. 599. 118454–118454. 1 indexed citations
3.
Shao, Dantong, Junjie Qin, Junming Xu, et al.. (2024). Non-invasive early detection on esophageal squamous cell carcinoma and precancerous lesions by microbial biomarkers combining epidemiological factors in China. Journal of Gastroenterology. 59(7). 531–542. 7 indexed citations
4.
Chen, Ru, Lizhou Dou, Jiachen Zhou, et al.. (2023). Optimal starting age of endoscopic screening for esophageal cancer in China: A multicenter prospective cohort study. Cancer Medicine. 12(8). 9988–9998. 5 indexed citations
5.
Shen, Yi, Shuanghua Xie, Lei Zhao, et al.. (2021). Estimating Individualized Absolute Risk for Esophageal Squamous Cell Carcinoma: A Population-Based Study in High-Risk Areas of China. Frontiers in Oncology. 10. 598603–598603. 17 indexed citations
6.
Dou, Lizhou, Yueming Zhang, Shun He, et al.. (2021). Characterization of the Oral and Esophageal Microbiota in Esophageal Precancerous Lesions and Squamous Cell Carcinoma. Frontiers in Cellular and Infection Microbiology. 11. 714162–714162. 27 indexed citations
7.
Xie, Shuanghua, Shaoming Wang, Liyan Xue, et al.. (2020). Helicobacter pylori Is Associated With Precancerous and Cancerous Lesions of the Gastric Cardia Mucosa: Results of a Large Population-Based Study in China. Frontiers in Oncology. 10. 205–205. 17 indexed citations
8.
Wei, Wenqiang, Changqing Hao, Guohui Song, et al.. (2020). Esophageal Histological Precursor Lesions and Subsequent 8.5-Year Cancer Risk in a Population-Based Prospective Study in China. The American Journal of Gastroenterology. 115(7). 1036–1044. 47 indexed citations
9.
Wang, Meng, Changqing Hao, Shuanghua Xie, et al.. (2019). Efficacy of endoscopic treatment on patients with severe dysplasia/carcinoma in situ of esophageal squamous cell carcinoma: A prospective cohort study. Chinese Journal of Cancer Research. 31(2). 357–365. 8 indexed citations
11.
Song, Guohui, et al.. (2018). Endoscopy screening effect on stage distributions of esophageal cancer: A cluster randomized cohort study in China. Cancer Science. 109(6). 1995–2002. 24 indexed citations
12.
Chen, Qiong, Changqing Hao, Jinwu Wang, et al.. (2016). Effectiveness of endoscopic gastric cancer screening in a rural area of Linzhou, China: results from a case–control study. Cancer Medicine. 5(9). 2615–2622. 45 indexed citations
13.
Wang, Meng, Changqing Hao, Qing Ma, et al.. (2016). DNA image cytometry test for primary screening of esophageal cancer: a population-based multi-center study in high-risk areas in China. Chinese Journal of Cancer Research. 28(4). 404–412. 9 indexed citations
14.
Chen, Qiong, Changqing Hao, Jinwu Wang, et al.. (2016). Effectiveness evaluation of organized screening for esophageal cancer: a case-control study in Linzhou city, China. Scientific Reports. 6(1). 35707–35707. 24 indexed citations
15.
Feng, Hao, Guohui Song, Juan Yang, et al.. (2015). [Cost-effectiveness analysis of esophageal cancer once-in-a-lifetime endoscopic screening in high-risk areas of rural China].. PubMed. 37(6). 476–80. 8 indexed citations
16.
Shao, Feifei, Changqing Hao, Lei Ni, et al.. (2013). Experimental and theoretical research on N-methyl-2-pyrrolidone concentration by vacuum membrane distillation using polypropylene hollow fiber membrane. Journal of Membrane Science. 452. 157–164. 31 indexed citations
17.
Wang, Guoqing, et al.. (2013). [Long-term outcomes of endoscopic argon plasma coagulation (APC) therapy for early esophageal cancer and precancerous lesions].. PubMed. 35(6). 456–8. 7 indexed citations
18.
Wang, Guoqing, et al.. (2008). Long-term survival rate of precancerous lesions and early esophageal cancers after endoscopic mucosal resection. Zhonghua xiaohua neijing zazhi. 25(11). 584–586. 3 indexed citations
19.
20.
Zhang, Yueming, Shun He, Changqing Hao, et al.. (2007). Evaluation of narrow-banding imaging endoscopy in the diagnosis of early squamous esophageal cancer and precancerous lesions. Zhonghua xiaohua neijing zazhi. 24(6). 410–414. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026